Imunon, Inc. (IMNN)
1.28
-0.04
(-3.03%)
USD |
NASDAQ |
Oct 02, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Imunon Enterprise Value : 6.953M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.953M |
| October 01, 2026 | 7.140M |
| September 30, 2026 | 7.000M |
| September 29, 2026 | 7.210M |
| September 28, 2026 | 7.420M |
| September 25, 2026 | 7.560M |
| September 24, 2026 | 7.280M |
| September 23, 2026 | 7.840M |
| September 22, 2026 | 8.026M |
| September 21, 2026 | 7.653M |
| September 18, 2026 | 7.326M |
| September 17, 2026 | 7.420M |
| September 16, 2026 | 7.560M |
| September 15, 2026 | 7.513M |
| September 14, 2026 | 7.816M |
| September 11, 2026 | 7.840M |
| September 10, 2026 | 7.746M |
| September 09, 2026 | 8.026M |
| September 08, 2026 | 8.166M |
| September 04, 2026 | 8.353M |
| September 03, 2026 | 8.259M |
| September 02, 2026 | 8.259M |
| September 01, 2026 | 8.446M |
| August 31, 2026 | 8.586M |
| August 28, 2026 | 8.446M |
| Date | Value |
|---|---|
| August 27, 2026 | 8.446M |
| August 26, 2026 | 8.586M |
| August 25, 2026 | 8.726M |
| August 24, 2026 | 8.399M |
| August 21, 2026 | 8.633M |
| August 20, 2026 | 8.353M |
| August 19, 2026 | 8.353M |
| August 18, 2026 | 8.353M |
| August 17, 2026 | 8.446M |
| August 14, 2026 | 8.679M |
| August 13, 2026 | 8.353M |
| August 12, 2026 | 8.493M |
| August 11, 2026 | 8.493M |
| August 10, 2026 | 8.586M |
| August 07, 2026 | 8.493M |
| August 06, 2026 | 8.353M |
| August 05, 2026 | 8.399M |
| August 04, 2026 | 8.773M |
| August 03, 2026 | 8.353M |
| July 31, 2026 | 8.399M |
| July 30, 2026 | 8.446M |
| July 29, 2026 | 8.166M |
| July 28, 2026 | 8.119M |
| July 27, 2026 | 8.119M |
| July 24, 2026 | 8.026M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 620.93M |
| Amgen, Inc. | 261.20B |
| BioCryst Pharmaceuticals, Inc. | 2.569B |
| Curis, Inc. | -3.007M |
| CEL-SCI Corp. | 42.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.814M |
| Total Expenses (Quarterly) | 2.814M |
| EPS Diluted (Quarterly) | -0.5412 |
| Earnings Yield | -300.2% |
| Normalized Earnings Yield | -300.45 |